The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort
What's the research behind GLP-1 medications affecting birth control effectiveness
Importantly, exerciseonly participants sustained substantially more weight loss than those on liraglutide alone, who regained most of the weight lost and approached placebo levels
Judging the medicine on the first month, or on the starter dose alone, is the most common reason patients feel it "isn't working"
Avoid alcohol-based mouthwash and limit caffeine or alcohol, both of which dry the mouth
DV: Validation, Resources, Data curation, Methodology, Software, Writing original draft, Investigation